- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
CPhI, ICSE, InnoPack, and P-MEC Europe
CPhI Worldwide is the world's leading pharmaceutical networking event for Pharma Ingredients. Along with co-located events ICSE for Contract Services, InnoPack for Innovative Packaging and P-MEC Europe for Technology, Equipment and Machinery, this is a one-stop shop event that cannot be missed by anyone serving the (Bio)Pharmaceutical industry.
CPhI Worldwide is the world's leading pharmaceutical networking event for Pharma Ingredients. Along with co-located events ICSE for Contract Services, InnoPack for Innovative Packaging and P-MEC Europe for Technology, Equipment and Machinery, this is a one-stop shop event that cannot be missed by anyone serving the (Bio)Pharmaceutical industry.
First launched in 1990, the events have grown to a scope of 2,200 exhibitors and 30,000+ attendees fromover 140 countries. An ideal networking platform, CPhI and co-located events allow you to meet all your business partners under one roof!
CPhI and co-located events host zones for each area of Pharma. From APIs to Generics, from Fine Chemicals to Intermediates and Finished Dosage, Custom Manufacturing and Clinical Trials to Transportation, Lab Devices, Track and Trace and much more.
Where else in the world can you find this many Pharma companies, showcasing their innovations, looking to meet people just like you?
Drop by from 9-11 October 2012 in Feria de Madrid, Spain. Admission is Free of Charge when you register online, unless you purchase a special package.
Register your interest now . We look forward to seeing you there!
Date: October 9, 2012 - October 11, 2012
Contact Info
Website: www.cphi.com
E-mail: cphi@ubm.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
